Investor Relations
BIOQUAL, Inc. is a public company traded on the Pink Sheets - Symbol BIOQ.

BIOQUAL, Inc.'s transfer agent is:
Registrar and Transfer Company
10 Commerce Drive
Cranford, New Jersey 07016
(800) 368-5948

Contact
Michael O'Flaherty
Chief Operating Officer
Corporate Secretary
BIOQUAL, Inc. 9600 Medical Center Drive
Rockville, MD 20850-3336
Phone: (301) 251-2801
Fax: (301) 251-1260


Financial Reports and Press Releases

BIOQUAL Presents Financial Results for FY 2013 Second Quarter Ending November 30, 2012 [Updated 03/12/13]

BIOQUAL Presents Financial Results for FY 2013 First Quarter Ending August 31, 2012 [Updated 12/19/12]

John Landon Letter To Shareholders [12/19/12]

Management’s Discussion and Analysis Related to the Audited Financial Statements for Fiscal Year 2012 [Updated 11/12/12]

BIOQUAL, Inc. and Subsidiary Presents Audited Financial Statements for Fiscal Year 2012 [Updated 11/12/12]

Press Release, 11/12/12, BIOQUAL, Inc. and Subsidiary Presents Financial Results for Fiscal Year 2012 and Declares Dividend

Press Release, 07/05/12, BIOQUAL, Inc. and Subsidiary Announces that the National Cancer Institute will not Exercise the Final Option for a Mouse Breeding Colony

BIOQUAL Presents Financial Results for FY 2012 Third Quarter Ending February 29, 2012 [Updated 05/02/12]

John Landon Letter To Shareholders [10/19/11]

Management’s Discussion and Analysis Related to the Audited Financial Statements for Fiscal Year 2011 [Updated 10/19/11]

BIOQUAL, Inc. and Subsidiary Presents Audited Financial Statements for Fiscal Year 2011 [Updated 09/06/11]

Press Release, 09/06/11, BIOQUAL, Inc. and Subsidiary Presents Financial Results for Fiscal Year 2011 and Declares Dividend

Press Release, 11/15/10, BIOQUAL, Inc. and Subsidiary Names Dr. Mark Lewis President

John Landon Letter To Shareholders [10/26/10]

Management’s Discussion and Analysis Related to the Audited Financial Statements for Fiscal Year 2010 [Updated [10/26/10]

Press Release, 09/13/10, BIOQUAL, Inc. and Subsidiary Presents Financial Results for Fiscal Year 2010 and Declares Dividend

BIOQUAL, Inc. and Subsidiary Presents Audited Financial Statements for Fiscal Year 2010 [Updated 09/13/10]

Contact
John C. Landon, Ph.D.
President/CEO
BIOQUAL, Inc.
9600 Medical Center Drive
Rockville, MD 20850-3336
Phone: (301) 251-2801
Fax: (301) 251-1260